UY26170A1 - ANTIGEN (C42) ASSOCIATED WITH TUMORS - Google Patents

ANTIGEN (C42) ASSOCIATED WITH TUMORS

Info

Publication number
UY26170A1
UY26170A1 UY26170A UY26170A UY26170A1 UY 26170 A1 UY26170 A1 UY 26170A1 UY 26170 A UY26170 A UY 26170A UY 26170 A UY26170 A UY 26170A UY 26170 A1 UY26170 A1 UY 26170A1
Authority
UY
Uruguay
Prior art keywords
antigen
tumors
immunotherapy
encode
tumor
Prior art date
Application number
UY26170A
Other languages
Spanish (es)
Inventor
Wolfgang Sommergruber
Ulrich Koenig
Karl-Heinz Heider
Guenther Adolf
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of UY26170A1 publication Critical patent/UY26170A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Antígeno asociado a tumores, péptidos inmunógenos derivados de éste, y moléculas de ADN que lo codifican, así como su utilización en la inmunoterapia de enfermedades de cáncer.Tumor-associated antigen, immunogenic peptides derived from it, and DNA molecules that encode it, as well as its use in the immunotherapy of cancer diseases.

UY26170A 1999-05-27 2000-05-26 ANTIGEN (C42) ASSOCIATED WITH TUMORS UY26170A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19924199A DE19924199A1 (en) 1999-05-27 1999-05-27 Tumor Associated Antigen

Publications (1)

Publication Number Publication Date
UY26170A1 true UY26170A1 (en) 2000-12-29

Family

ID=7909293

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26170A UY26170A1 (en) 1999-05-27 2000-05-26 ANTIGEN (C42) ASSOCIATED WITH TUMORS

Country Status (10)

Country Link
EP (1) EP1183349A1 (en)
JP (1) JP2003501025A (en)
AR (1) AR024114A1 (en)
AU (1) AU4924000A (en)
CA (1) CA2376133A1 (en)
CO (1) CO5280140A1 (en)
DE (1) DE19924199A1 (en)
MX (1) MXPA01012012A (en)
UY (1) UY26170A1 (en)
WO (1) WO2000073438A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7338937B2 (en) * 1997-11-17 2008-03-04 Cornell Research Foundation, Inc. Calcium-activated chloride channel proteins and their use in anti-metastatic therapy
US7049063B2 (en) 1998-03-18 2006-05-23 Corixa Corporation Methods for diagnosis of lung cancer
US7579160B2 (en) 1998-03-18 2009-08-25 Corixa Corporation Methods for the detection of cervical cancer
US7141365B2 (en) * 2001-05-18 2006-11-28 Syntex (U.S.A.) Llc Methods for diagnosing a mucin production associated disease condition
ATE494387T1 (en) 2001-11-07 2011-01-15 Mannkind Corp EXPRESSION VECTORS ENCODING EPITOPES OF ANTIGENS AND METHOD FOR THE CONCEPTION THEREOF
US20050221350A1 (en) 2002-05-29 2005-10-06 Toni Weinschenk Method for identifying immunoreactive peptides
DE102005041616B4 (en) * 2005-09-01 2011-03-17 Johannes-Gutenberg-Universität Mainz Melanoma associated MHC class I associated oligopeptides and polynucleotides encoding them and their uses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE345387T1 (en) * 1998-03-18 2006-12-15 Corixa Corp COMPOUNDS AND METHODS FOR THERAPY AND DIAGNOSIS OF LUNG CANCER
WO2000012711A2 (en) * 1998-09-02 2000-03-09 Incyte Pharmaceuticals, Inc. Human membrane channel proteins

Also Published As

Publication number Publication date
WO2000073438A1 (en) 2000-12-07
MXPA01012012A (en) 2002-06-21
AU4924000A (en) 2000-12-18
DE19924199A1 (en) 2000-11-30
CO5280140A1 (en) 2003-05-30
CA2376133A1 (en) 2000-12-07
EP1183349A1 (en) 2002-03-06
AR024114A1 (en) 2002-09-04
JP2003501025A (en) 2003-01-14

Similar Documents

Publication Publication Date Title
TW581808B (en) Compounds for immunotherapy of prostate cancer and methods for their use
MXPA05008128A (en) Survivin-derived peptides and use thereof.
AU2003242305A1 (en) Hla-a24-restricted cancer antigen peptide
WO1998037093A3 (en) Compounds for immunotherapy of prostate cancer and methods for their use
AR006250A1 (en) COMPOUNDS AND METHODS FOR IMMUNOTHERAPY AND IMMUNODIAGNOSIS OF PROSTATIC CANCER
BR9908823A (en) Lung cancer therapy and diagnosis compounds and processes
CY1108960T1 (en) CRIPTO EXCLUSION COTTAGES AND THEIR USES
IL163902A0 (en) Antibodies against cancer antigen tmeff2 and uses thereof
WO2004050707A3 (en) Tumor-specific recognition molecules
MY136095A (en) Use of human anti-ctla-4 antibodies for treatment of cancer
CY1111147T1 (en) TRANSMISSIONAL CYCLE TRANSMISSIONAL LIGGIN ANTIGEN IN HUMAN PROTECTOR AND HIS USE
ATE347904T1 (en) CANCER IMMUNOTHERAPY AND CANCER DIAGNOSIS USING UNIVERSAL TUMOR-ASSOCIATED ANTIGENS INCLUDING HTERT
BR0306715A (en) Methods for diagnosis and treatment of tumors
EP1708751A4 (en) Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells
WO2003104425A3 (en) Novel stable anti-cd22 antibodies
MXPA05008794A (en) Glycorpotein antigen sima135 expressed in metastatic human tumor cells.
UY26266A1 (en) ANTIGEN ASSOCIATED WITH TUMORS (R11) LAW 17164
DK1082423T3 (en) Cyclin E2 genes and proteins
UY26170A1 (en) ANTIGEN (C42) ASSOCIATED WITH TUMORS
WO2005099361A3 (en) MHC CLASS I - PEPTIDE-ANTIBODY CONJUGATES WITH MODIFIED β2-MICROGLOBULIN
IL207012A0 (en) Diagnosis and therapy of cancer using sgp28-related molecules
ATE525401T1 (en) MHC CLASS I AND II PEPTIDE ANTIGENS DERIVED FROM TUMOR ANTIGEN 5T4
AR023794A1 (en) ANTIGEN ASSOCIATED WITH TUMORS
UY26127A1 (en) ANTIGEN ASSOCIATED WITH TUMORS
CY1111320T1 (en) CRIPTO SPECIAL ANTIBODIES

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20100427